Pfizer Issues Recall of Penicillin Injection as Syphilis Treatment Gains at Risk

Pfizer is issuing a recall of its Bicillin L-A penicillin injection, which is used to treat syphilis, due to low supply levels, potentially putting gains against the disease at risk. This recall may lead to disruptions in treatment for patients and healthcare providers. Doctors are being warned to be prepared for potential shortages of the antibiotic as a result. The shortage could have significant implications for public health efforts to combat syphilis.